Dr. Aman M. Shah, MD
Claim this profileSt Francis Hospital
Studies Heart Failure
Studies Congestive Heart Failure
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Aman M. Shah, MD is currently running
Edwards PASCAL System
for Tricuspid Regurgitation
This trial tests a new device that fixes a leaky heart valve without surgery in patients who are too risky for traditional surgery. The device helps the valve close properly to stop blood from leaking backward. The first device specifically designed for this purpose is the paravalvular leak device (PLD - Occlutech).
Recruiting1 award N/A6 criteria
Doraya Catheter
for Heart Failure
This trial is testing the Doraya Catheter, a device that helps manage fluid levels, in heart failure patients who do not respond well to typical treatments. The catheter works by controlling and managing excess fluid in the body.
Recruiting1 award N/A4 criteria
More about Aman M. Shah, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Aman M. Shah, MD has experience with
- Standard Of Care
- Doraya Catheter
- Edwards PASCAL System
- Optimal Medical Therapy
Breakdown of trials Aman M. Shah, MD has run
Heart Failure
Congestive Heart Failure
Tricuspid Regurgitation
Tricuspid Valve Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Aman M. Shah, MD specialize in?
Is Aman M. Shah, MD currently recruiting for clinical trials?
Are there any treatments that Aman M. Shah, MD has studied deeply?
What is the best way to schedule an appointment with Aman M. Shah, MD?
What is the office address of Aman M. Shah, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.